€19.50
0.25% today
Xetra, Nov 21, 05:15 pm CET
ISIN
DE000BAY0017
Symbol
BAYN
Sector
Industry

Bayer Stock News

Neutral
Business Wire
about 3 hours ago
ST. LOUIS--(BUSINESS WIRE)--Bayer announced today an expanded approach to its programs that sequester carbon and reduce emissions for companies along the food value chain through regenerative agriculture practices. In addition to helping to reduce these companies' Scope 3 emissions, “Project Enhanced S3” will include data on benefits from regenerative agriculture practices, such as soil health,...
AD HOC NEWS
about 18 hours ago
Die Talfahrt der BayerDE000BAY0017-Aktie hat sich am Donnerstag mit einem Tief seit mehr als zwei Dekaden fortgesetzt.
AD HOC NEWS
one day ago
Das Analysehaus Jefferies hat das Kursziel für Bayer DE000BAY0017 von 29 auf 22 Euro gesenkt und die Einstufung auf "Hold" belassen.
Positive
Reuters
2 days ago
Bayer on Tuesday struck a collaboration deal with U.S. biotech firm Cytokinetics to acquire certain rights in Japan to an experimental heart drug, as the German group strengthens its cardiovascular business with smaller deals.
Negative
Reuters
6 days ago
Some Bayer investors say CEO Bill Anderson should speed up turnaround efforts, including boosting efficiency and drug development, to restore confidence and revive the company's share price that hit 20-year lows after its shock warning this week.
Neutral
Business Wire
7 days ago
WHIPPANY, N.J.--(BUSINESS WIRE)--Bayer will present three new prespecified subgroup analyses from the pivotal Phase III FINEARTS-HF cardiovascular outcomes trial investigating KERENDIA® (finerenone) in heart failure (HF) patients with a left ventricular ejection fraction (LVEF) of ≥40%, in a Featured Science session at the American Heart Association (AHA) Scientific Sessions 2024, taking place ...
AD HOC NEWS
9 days ago
Die US-Investmentbank Goldman Sachs hat das Kursziel für Bayer DE000BAY0017 von 30 auf 27 Euro gesenkt, aber die Einstufung auf "Neutral" belassen.
Neutral
Seeking Alpha
9 days ago
Bayer AG (OTCPK:BAYZF) Q3 2024 Earnings Conference Call November 12, 2024 8:00 AM ET Company Participants Bill Anderson - Chairman & CEO Wolfgang Nickl - CFO Julio Triana - President, Consumer Health Division Stefan Oelrich - President, Pharmaceuticals Division Rodrigo Santos - President, Crop Science Division Jost Reinhard - IR Conference Call Participants Vincent Andrews - Morgan Stanley Sach...

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today